On the other hand, cognitive dysfunction and Alzheimer’s disease in humans are linked to higher serum adiponectin levels22–25, although evidence regarding CSF adiponectin levels in Mild Cognitive Impairment (MCI)/AD patients remains controversial23,24. This evidence concerns the gene ADIPOQ and early-onset autosomal dominant Alzheimer disease.